HIRA’s CDDC seeks to revise current regulations
By Lee, Tak-Sun | translator Kim, Jung-Ju
24.03.14 14:46:19
가나다라
0
Meeting members will consist of no more than 25 members including 9 clinical experts
Members for each meeting will be based on specialty area and agenda
The measure was prepared to maintain consistency in the committee’s deliberations. In addition, the Korean Association for Lung Cancer will be added as a recommended organization given that lung cancer drugs are often on the agenda.
The Health Insurance Review and Assessment Service issued a notice of the proposed amendments to the Operating Regulations for the Severe Disease Review Committee (Cancer Disease Review Committee, CDDC) on the 13th of this month.
The amendments were made for the following reasons: ▲ to specify the legal grounds for establishing
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)